Ohmi Kazuhiro, Greenberg David S, Rajavel Kavitha S, Ryazantsev Sergey, Li Hong Hua, Neufeld Elizabeth F
Department of Biological Chemistry, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1902-7. doi: 10.1073/pnas.252784899. Epub 2003 Feb 7.
Alpha-N-acetylglucosaminidase deficiency (mucopolysaccharidosis IIIB, MPS IIIB) and alpha-l-iduronidase deficiency (MPS I) are heritable lysosomal storage diseases; neurodegeneration is prominent in MPS IIIB and in severe cases of MPS I. We have obtained morphologic and molecular evidence for the involvement of microglia in brain pathology of mouse models of the two diseases. In the cortex, a subset of microglia (sometimes perineuronal) consists of cells that are probably phagocytic; they have large storage vacuoles, react with MOMA-2 (monoclonal antibody against macrophages) and Griffonia simplicifolia isolectin IB(4), and stain intensely for the lysosomal proteins Lamp-1, Lamp-2, and cathepsin D as well as for G(M3) ganglioside. MOMA-2-positive cells appear at 1 and 6 months in MPS IIIB and MPS I mice, respectively, but though their number increases with age, they remain sparse. However, a profusion of cells carrying the macrophage CD68/macrosialin antigen appear in the cortex of both mouse models at 1 month. mRNA encoding CD68/macrosialin also increases at that time, as shown by microarray and Northern blot analyses. Ten other transcripts elevated in both mouse models are associated with macrophage functions, including complement C4, the three subunits of complement C1q, lysozyme M, cathepsins S and Z, cytochrome b558 small subunit, macrophage-specific protein 1, and DAP12. An increase in IFN-gamma and IFN-gamma receptor was observed by immunohistochemistry. These functional increases may represent activation of resident microglia, an influx and activation of blood monocytes, or both. They show an inflammatory component of brain disease in the two MPS, as is known for many neurodegenerative disorders.
α-N-乙酰氨基葡萄糖苷酶缺乏症(黏多糖贮积症IIIB型,MPS IIIB)和α-L-艾杜糖醛酸酶缺乏症(MPS I)是遗传性溶酶体贮积病;神经退行性变在MPS IIIB以及MPS I的严重病例中较为突出。我们已经获得形态学和分子证据,表明小胶质细胞参与了这两种疾病小鼠模型的脑病理学过程。在皮质中,一部分小胶质细胞(有时围绕神经元)由可能具有吞噬作用的细胞组成;它们有大的贮积空泡,与MOMA-2(抗巨噬细胞单克隆抗体)和西非单叶豆凝集素IB(4)发生反应,并且对溶酶体蛋白Lamp-1、Lamp-2和组织蛋白酶D以及神经节苷脂G(M3)染色强烈。MOMA-2阳性细胞分别在MPS IIIB和MPS I小鼠的1个月和6个月时出现,但尽管其数量随年龄增加,它们仍然稀少。然而,在1个月时,两种小鼠模型的皮质中都出现了大量携带巨噬细胞CD68/巨噬涎蛋白抗原阳性的细胞。微阵列和Northern印迹分析显示,编码CD68/巨噬涎蛋白的mRNA在此时也增加。在两种小鼠模型中升高的其他10种转录物与巨噬细胞功能相关,包括补体C4、补体C1q的三个亚基、溶菌酶M、组织蛋白酶S和Z、细胞色素b558小亚基、巨噬细胞特异性蛋白1和DAP12。通过免疫组织化学观察到干扰素-γ和干扰素-γ受体增加。这些功能增强可能代表驻留小胶质细胞的激活、血液单核细胞的流入和激活,或两者兼有。它们显示了这两种MPS脑疾病中的炎症成分,这在许多神经退行性疾病中是已知的。